neurodegeneration therapy (KDev Exploratory AB)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameneurodegeneration therapy (KDev Exploratory AB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska Development (Kdev)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKarolinska Development (Kdev)
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A